Breaking News Instant updates and real-time market news.

VC

Visteon

$93.22

0.37 (0.40%)

08:49
10/02/18
10/02
08:49
10/02/18
08:49

Visteon initiated with a Peer Perform at Wolfe Research

VC Visteon
$93.22

0.37 (0.40%)

10/01/18
BARD
10/01/18
DOWNGRADE
BARD
Neutral
Autoliv, TE Connectivity, Methode Electronics downgraded to Neutral at Baird
Baird analyst David Leiker downgraded Autoliv (ALV), Methode Electronics (MEI) and TE Connectivity (TEL) to Neutral from Outperform and lowered his respective price targets to $90 from $120, $39 from $47 and $93 from $105, telling investors in a research note that risk/reward is seen in balance. In a research note on the global automotive sector to investors, Leiker says that while the magnitude of BMW's (BMWYY) recent update equals other adjustments already made, stocks are reacting poorly and current downtrend suggests valuation disconnect will likely persist until greater clarify on 2019 is offered. Top names remain Aptiv (APTV), Lear (LEA) and Visteon (VC), while BorgWarner (BWA), Delphi (DLPH) and Littelfuse (LFUS) remain Outperform-rated.
08/08/18
BARD
08/08/18
NO CHANGE
Target $175
BARD
Outperform
Visteon elevated to Fresh Pick and Top Idea at Baird
Baird analyst David Leiker elevated Visteon to Fresh Pick and Top Idea following Q2 results. The analyst believes the sentiment has deteriorated and that beating expectations on near-term estimates will restore confidence and drive a 20% rally for the stock. He said the backlog still supports his intermediate revenue targets and that headwinds are not backlog related. Leiker reiterated his Outperform rating and $175 price target on Visteon shares.
07/18/18
07/18/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Twitter (TWTR) downgraded to Neutral from Outperform at Macquarie with analyst Benjamin Schachter citing concerns about MAU trends, what he views as a limited set of near-term catalysts and a valuation he believes will likely limit upside from current levels. 2. Clorox (CLX) downgraded to Sell from Neutral at Goldman Sachs with analyst Jason English citing a combination of a lower volume forecast, lower gross margin expectation and renewed currency headwinds. 3. Autoliv (ALV) and Visteon (VC) were downgraded to Market Perform from Outperform at Wells Fargo. 4. Broadcom (AVGO) downgraded to Neutral from Buy at Goldman Sachs with analyst Toshiya Hari saying he sees increased uncertainty surrounding the company's "strategic focus going forward" following its acquisition of CA Technologies (CA). 5. Windstream (WIN) and Uniti Group (UNIT) were downgraded to Sell from Neutral at Citi. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/18/18
WELS
07/18/18
DOWNGRADE
Target $137
WELS
Market Perform
Visteon downgraded to Market Perform on limited upside potential at Wells Fargo
As previously reported, Wells Fargo analyst Richard Kwas downgraded Visteon to Market Perform from Outperform ahead of quarterly results. While the analyst thinks the long-term strategy is compelling, he just sees limited upside potential at the present time. Kwas believes the company is better insulated than most from tariff headwinds but that is reflected in the stock. The analyst also lowered his price target on the shares to $137 from $146.

TODAY'S FREE FLY STORIES

KOF

Coca-Cola Femsa

$59.41

-1.75 (-2.86%)

09:36
10/23/18
10/23
09:36
10/23/18
09:36
Upgrade
Coca-Cola Femsa rating change  »

Coca-Cola Femsa upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$47.93

0.34 (0.71%)

09:35
10/23/18
10/23
09:35
10/23/18
09:35
Initiation
Oracle initiated  »

Oracle initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 14

    Nov

09:35
10/23/18
10/23
09:35
10/23/18
09:35
Conference/Events
JPMorgan European & EMEA analysts to hold analyst/industry conference call »

European Utilities…

ABBV

AbbVie

09:35
10/23/18
10/23
09:35
10/23/18
09:35
Initiation
AbbVie initiated  »

AbbVie initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

SNY

Sanofi

09:35
10/23/18
10/23
09:35
10/23/18
09:35
Initiation
Sanofi initiated  »

Sanofi reinitiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 28

    Oct

  • 29

    Oct

  • 28

    Jan

  • 22

    Mar

  • 28

    Apr

RHHBY

Roche

09:35
10/23/18
10/23
09:35
10/23/18
09:35
Initiation
Roche initiated  »

Roche reinitiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 24

    Dec

09:35
10/23/18
10/23
09:35
10/23/18
09:35
General news
Treasury 2-year auction outlook: the $38 B 2-year sale »

Treasury 2-year auction…

PFE

Pfizer

$44.37

-0.13 (-0.29%)

09:34
10/23/18
10/23
09:34
10/23/18
09:34
Initiation
Pfizer initiated  »

Pfizer reinitiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 07

    Nov

GSK

GlaxoSmithKline

09:34
10/23/18
10/23
09:34
10/23/18
09:34
Initiation
GlaxoSmithKline initiated  »

GlaxoSmithKline…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 31

    Oct

  • 07

    Nov

LLY

Eli Lilly

09:34
10/23/18
10/23
09:34
10/23/18
09:34
Initiation
Eli Lilly initiated  »

Eli Lilly reinitiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 07

    Nov

NVS

Novartis

$87.12

-0.07 (-0.08%)

09:34
10/23/18
10/23
09:34
10/23/18
09:34
Initiation
Novartis initiated  »

Novartis reinitiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

MRK

Merck

$72.56

0.22 (0.30%)

09:34
10/23/18
10/23
09:34
10/23/18
09:34
Initiation
Merck initiated  »

Merck reinitiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 25

    Oct

  • 29

    Oct

  • 11

    Jan

  • 16

    Feb

BMY

Bristol-Myers

$50.87

-3.44 (-6.33%)

09:34
10/23/18
10/23
09:34
10/23/18
09:34
Initiation
Bristol-Myers initiated  »

Bristol-Myers reinitiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 29

    Oct

  • 07

    Nov

  • 20

    May

AZN

AstraZeneca

$39.50

0.295 (0.75%)

09:34
10/23/18
10/23
09:34
10/23/18
09:34
Initiation
AstraZeneca initiated  »

AstraZeneca reinitiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 07

    Nov

MLCO

Melco Resorts & Entertainment

$17.74

-0.04 (-0.22%)

09:34
10/23/18
10/23
09:34
10/23/18
09:34
Downgrade
Melco Resorts & Entertainment rating change  »

Melco Resorts &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLF

Financial Select Sector

$26.10

-0.56 (-2.10%)

, BAC

Bank of America

$27.36

-0.95 (-3.36%)

09:33
10/23/18
10/23
09:33
10/23/18
09:33
Technical Analysis
Technical Take: Bank of America drops in early trading »

The shares were last down…

XLF

Financial Select Sector

$26.10

-0.56 (-2.10%)

BAC

Bank of America

$27.36

-0.95 (-3.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

UTX

United Technologies

$126.42

-2.22 (-1.73%)

09:33
10/23/18
10/23
09:33
10/23/18
09:33
Hot Stocks
United Technologies says geo-political outlook is the biggest concern »

Says tariffs present a 5c…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

UBS

UBS

$13.77

-0.085 (-0.61%)

09:32
10/23/18
10/23
09:32
10/23/18
09:32
Periodicals
UBS backs down warning to staff about traveling to China, FT reports »

UBS has rescinded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXPI

eXp World Holdings

$12.50

0.35 (2.88%)

09:31
10/23/18
10/23
09:31
10/23/18
09:31
Hot Stocks
eXp Realty to acquire ShowMeNow, terms not disclosed »

eXp Realty, a subsidiary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

HOG

Harley-Davidson

$38.72

-0.84 (-2.12%)

09:31
10/23/18
10/23
09:31
10/23/18
09:31
Hot Stocks
Harley-Davidson says FY18 shipments will finish at low-end of guidance range »

Management says adapting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

ORCL

Oracle

$47.93

0.34 (0.71%)

, AMZN

Amazon.com

$1,789.00

25.09 (1.42%)

09:30
10/23/18
10/23
09:30
10/23/18
09:30
Periodicals
Move from Oracle cause of Amazon warehouse outage on Prime Day, CNBC says »

Amazon (AMZN) dealt with…

ORCL

Oracle

$47.93

0.34 (0.71%)

AMZN

Amazon.com

$1,789.00

25.09 (1.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 14

    Nov

HAL

Halliburton

$36.36

-1.18 (-3.14%)

09:30
10/23/18
10/23
09:30
10/23/18
09:30
Recommendations
Halliburton analyst commentary  »

Halliburton price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBAN

Huntington Bancshares

$13.66

-0.54 (-3.80%)

09:27
10/23/18
10/23
09:27
10/23/18
09:27
Hot Stocks
Huntington Bancshares to make targeted investments in people, technology »

Says local economies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 25

    Oct

YMAB

Y-mAbs Therapeutics

$22.00

0.02 (0.09%)

09:27
10/23/18
10/23
09:27
10/23/18
09:27
Hot Stocks
Y-mAbs Therapeutics receives recommendation from COMP for OMPD for naxitamab »

Y-mAbs Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNAP

Snap

$6.84

0.02 (0.29%)

09:26
10/23/18
10/23
09:26
10/23/18
09:26
Upgrade
Snap rating change  »

Snap upgraded to Positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 25

    Oct

  • 07

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.